Asia-Pacific Over-the-counter (OTC) Drugs Market Share

Statistics for the 2023 & 2024 Asia-Pacific Over-the-counter (OTC) Drugs market share, created by Mordor Intelligence™ Industry Reports. Asia-Pacific Over-the-counter (OTC) Drugs share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Asia-Pacific Over-the-counter (OTC) Drugs Industry

The over-the-counter drugs market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with technological advancements and product innovation, mid-size to smaller companies are increasing their market presence by introducing new products with fewer prices. For instance, in April 2018, Procter & Gamble Company acquired the Consumer Health business of Merck KGaA. Companies, like Johnson & Johnson, GlaxoSmithKline PLC, and Sanofi, hold significant market shares in the over-the-counter drugs market.

Asia Pacific Over-The-Counter (OTC) Drugs Market Leaders

  1. GlaxoSmithKline PLC

  2. Johnson & Johnson

  3. Boehringer Ingelheim International GmbH

  4. Procter & Gamble

  5. Sanofi SA

*Disclaimer: Major Players sorted in no particular order

Johnson & Johnson,  Sanofi SA, GlaxoSmithKline PLC, Boehringer Ingelheim International GmbH, Abbott Laboratories, Dabur India Limited

Asia Pacific OTC Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)